Viewing Study NCT06683703


Ignite Creation Date: 2025-12-24 @ 7:10 PM
Ignite Modification Date: 2025-12-25 @ 4:44 PM
Study NCT ID: NCT06683703
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-11-12
First Post: 2024-11-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Utidelone Injection Combined with Bevacizumab Injection for Non-small Cell Lung Cancer Patients with Brain Metastases
Sponsor: Beijing Biostar Pharmaceuticals Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module